Organization
The University of Manchester, Centre for Epidemiology Versus Arthritis, Manchester, United Kingdom
4 abstracts
Abstract
ANALYSIS OF PROTEIN QUANTITATIVE TRAIL LOCI TO IDENTIFY GENETIC BIOMARKERS OF TREATMENT RESPONSE TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITISOrg: The University of Manchester, Centre for Genetics and Genomics Versus Arthritis, Manchester, United Kingdom, NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, University of Leeds, School of Medicine, Leeds, United Kingdom, NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom, NIHR In Vitro Diagnostic Co-Operative, Leeds, United Kingdom,
Abstract
BILAG-2004 INDEX ACTIVE DISEASE PREDICTS DEVELOPMENT OF DAMAGEOrg: Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Doncaster, United Kingdom, University of Cambridge, MRC Biostatistics Unit, Cambridge, United Kingdom, Sheffield Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Sheffield, United Kingdom, Nottingham University Hospitals NHS Trust, Department of Rheumatology, Nottingham, United Kingdom, University Hospital Southampton NHS Foundation Trust, Department of Rheumatology, Southampton, United Kingdom,
Abstract
BILAG-2004 LDA AND BST LDA ARE VALID TREAT TO TARGET IN SLEOrg: Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Doncaster, United Kingdom, University of Birmingham, Rheumatology Research Group, Birmingham, United Kingdom, Sheffield Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Sheffield, United Kingdom, Nottingham University Hospitals NHS Trust, Department of Rheumatology, Nottingham, United Kingdom, University Hospital Southampton NHS Foundation Trust, Department of Rheumatology, Southampton, United Kingdom,
Abstract
ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCEOrg: Brigham And Women’s Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, United States of America, Harvard Medical School, Division of Rheumatology, Inflammation, and Immunity, Boston, United States of America, Massachusetts General Hospital, Division of Rheumatology, Allergy, and Immunology, Boston, United States of America, University of California, San Francisco, Division of Rheumatology, San Francisco, United States of America, University of California, San Francisco, Department of Epidemiology and Biostatistics, San Francisco, United States of America,